BN Business News
Add your company to Business Communicator →

Business · 16/10/20261 min read

Myosin Therapeutics Invited to Present at BioFuture 2026 in New York City

Summary

Myosin Therapeutics has been invited to present at BioFuture 2026 in New York City, following its selection as a 2026–2027 National Cancer Institute SBIR Investor Initiatives Showcase Company.

Original source language: PR NewswireOpen original release →

Explore insights

Business insights →